Loss of PTPN2 or PTPN1 in T cells can decrease the TCR activation threshold owing to increased LCK and FYN phosphorylation, which could increase the recognition of less immunogenic tumour antigens11,12. This evidence concerns the gene PTPN2 and neoplasm.